Laboratory Corporation/Orchid Cellmark
On April 6, 2011, Laboratory Corporation of America Holdings (NYSE: LH) and Orchid Cellmark Inc. (Nasdaq: ORCH) announced that they have entered into an agreement whereby Lab Corp will acquire Orchid Cellmark for $2.80 per share in cash, or total consideration of $85.4 million.
Under the terms of the agreement and plan of merger, LabCorp has formed an acquisition subsidiary, OCM Acquisition Corp., that will commence a tender offer to purchase all outstanding shares of Orchid Cellmark for $2.80 per share.
Closing is expected in Q211.
Under the terms of the agreement and plan of merger, LabCorp has formed an acquisition subsidiary, OCM Acquisition Corp., that will commence a tender offer to purchase all outstanding shares of Orchid Cellmark for $2.80 per share.
Closing is expected in Q211.
-
Barclays Maintains an 'Overweight' on Laboratory Corporation (LH); Orchid Cellmark (ORCH) Deal Wins FTC Approval
-
Lab Corp (LH) Extends Tender for Orchid Cellmark (ORCH)
-
LabCorp (LH) Extends Cash Offer for Shares of Orchid Cellmark (ORCH)
-
Laboratory Corp. (LH) Extends $2.80/Share Tender for Orchid Cellmark (ORCH)
-
Unusual 11 Mid-Day Movers 04/06: (ORCH) (BLTI) (ABAT) Higher; (AMSC) (ONSM) (DYNT) Lower
-
Morning Movers 04/06: (ORCH) (SIMO) (BLTI) (HILL) Higher; (AMSC) (DYNT) Lower
-
Notable Mergers and Acquisitions of the Day 04/06: (LH)/(ORCH) (G) (MSCC)/(AMLJ) (CLH)
